Pharma - Industry – Focus

 

Custom Search

Cram business likely to get a boost in this slow-down period

With spiralling research costs, expiry of patent period, couple by advancement of Indian pharma companies will result in growth of contract research business. Many analyst predicts a growth of $ 3 biliion of cram business by 2015. Further, many Indian companies Divis Laboratories, Piramal Healthcare, Biocon have expanded recently their operations to accommodate this growth. Indian pharma industry, has similar strengths of IT (high skilled man-power at low costs, availability) is set to make this grow.

 

Custom Search

Copyright © 2013 Ibis Research Information Services Pvt Ltd. All Rights Reserved.
Contact : Ibis Research Information Services Pvt Ltd., 28, Rajaji Street, NGO Colony
Guduvancherry, Chennai -603 202   Mobile : 0-97898-37940 email : ibischennai@gmail.com Privacy Policy